HyperCORE International LLP is a super network of highly experienced and awarded clinical research site/network companies. The members and their companies have over 100 years of combined experience in the Clinical Trial space. Combined, they have completed more than 6,000 studies, assisting to evaluate thousands of new drugs and treatments in more than 60,000 patients. Each member operates as an independent company; however, each integrates common functions to streamline business and clinical operations through harmonization and sharing of best practices.
HyperCORE International is an industry leader, providing Phase I-IV clinical trial services. It’s the second largest, worldwide network of sites, with over 80 sites in five countries, and two continents. Its representatives are a combination of eight of the top leading clinical research companies in the world. HyperCORE aspires to centralize the main operations and innovative strategic partnerships with Sponsors and CROs. Its main objective is to innovate the existing inefficient model of Research Sites.
Its primary goal is to modernize the highly fragmented and inefficient research site model by assembling the industry’s leading site networks under one moniker, facilitating exponential efficiencies.
“This is the realization of a vision several years in the making. I wanted to bring together a group of already highly successful and professionalized research site businesses in a new and powerful way. The magic lies within the mutual ownership model. This motivates and ensures we each bring the best to the table and work together in ways not possible before. Together, we can push the boundaries, leading the drive for further innovation, something that will resonate across the clinical research industry. By banding together in such an intimate and integrated way, we can accelerate the entire end-to-end process from feasibility to close-out. Its research accelerated!”
Mark Lacy, CEO of Benchmark research and CEO of hyperCORE.
hyperCORE International’s founding partner members are:
- Benchmark Research of Austin, Texas
- Clinical Trials of Texas of San Antonio, Texas
- DIEX Research of Montreal, Canada
- FOMAT Medical Research of Oxnard, CA
- IACT Health of Columbus, Georgia
- LMC Manna Research of Toronto, Canada
- Research Centers of America (RCA) of Hollywood, Florida
- Wake Research of Raleigh, North Carolina
About FOMAT Medical Research:
FOMAT Medical Research is a modified and improved version of a traditional Site Management Organization with a highly qualified research site network. We offer a wide range of solutions for Sponsors, Clinical Contract Organizations (CROs), and Sites throughout the Americas. We have over 10 years of experience participating in Clinical Research in phase II-IV in most therapeutic areas.
“We are excited to be part of this research site network. I strongly believe that we can change the existing business model through this innovative collaboration that creates a more efficient approach for our sponsors and patients”
– Nicholas Focil, CEO FOMAT